7Baggers
 price to sales forward of 9 meters biopharma, inc. – otc:nmtrq  TradingView Sat, 04 Jul 2026 08:50:20 GMT
 Price to book forward of 9 Meters Biopharma, Inc. – OTC:NMTRQ  TradingView Sat, 04 Jul 2026 08:33:09 GMT
 top first tracks biotherapeutics (trax) competitors 2026  MarketBeat Fri, 26 Jun 2026 06:42:21 GMT
 Lilly licenses Hanmi GLP-2 drug in $1.26bn deal  pharmaphorum Mon, 01 Jun 2026 07:00:00 GMT
 number of shareholders of 9 meters biopharma, inc. – otc:nmtrq  TradingView Thu, 07 May 2026 23:46:20 GMT
 OZMOSI and Planview partner to enhance pharmaceutical data integration  Pharmaceutical Technology Fri, 24 Apr 2026 07:00:00 GMT
 bethany sensenig appointed to alpha board as director  TradingView Mon, 20 Apr 2026 21:03:00 GMT
 UCB to buy Neurona and NRTX-1001 for $1.15bn  Pharmaceutical Technology Mon, 20 Apr 2026 07:00:00 GMT
 ucb to purchase neurona and nrtx-1001 for $1.15bn  Pharmaceutical Technology Mon, 20 Apr 2026 07:00:00 GMT
 bethany sensenig joins alpha cognition (nasdaq: acog) board  Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
 alpha cognition appoints bethany sensenig to board of directors  Investing.com Mon, 20 Apr 2026 07:00:00 GMT
 stock list: research stocks from around the world  GuruFocus Sat, 28 Mar 2026 10:01:29 GMT
 stock list: research stocks from around the world  GuruFocus Wed, 25 Mar 2026 12:50:46 GMT
 pharmaceutical and biotechnology royalty rates agreements  GlobeNewswire Thu, 12 Mar 2026 07:00:00 GMT
 Novo Nordisk and Vivtex collaborate for oral medicines development  Pharmaceutical Technology Thu, 26 Feb 2026 08:00:00 GMT
 usa stocks: research stocks from usa stock market  GuruFocus Thu, 19 Feb 2026 23:38:19 GMT
 Peptide Therapeutics Market Trends and Global Forecasts to  GlobeNewswire Mon, 12 Jan 2026 08:00:00 GMT
 can 9 meters biopharma inc. (2q3a) stock deliver double digit returns  Улправда Thu, 08 Jan 2026 22:44:29 GMT
 celiac disease clinical trial pipeline gains momentum: 20+  GlobeNewswire Wed, 10 Dec 2025 08:00:00 GMT
 published on: 2025-11-13 14:26:04  earlytimes.in Thu, 13 Nov 2025 08:56:55 GMT
 WCG unveils Data & Insights Solutions for clinical trials  Clinical Trials Arena Thu, 13 Nov 2025 08:00:00 GMT
 celiac disease drugs market to reach usd 4.92 billion by 2034  openPR.com Mon, 10 Nov 2025 08:00:00 GMT
 Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats  Pharmaceutical Technology Wed, 05 Nov 2025 08:00:00 GMT
 kimberly-clark buys troubled tylenol-maker kenvue for $48.7bn  Pharmaceutical Technology Tue, 04 Nov 2025 08:00:00 GMT
 larazotide acetate: a pharmacological peptide approach to tight junction regulation  American Physiological Society Journal Thu, 23 Oct 2025 17:55:44 GMT
 published on: 2025-10-22 06:14:16  newser.com Wed, 22 Oct 2025 11:14:16 GMT
 will 9 meters biopharma inc. (2q3a) stock sustain bullish trend into 2025  Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 12:32:48 GMT
 data sharing is key to perfecting site selection and enrolment  Clinical Trials Arena Fri, 17 Oct 2025 07:00:00 GMT
 Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn  Pharmaceutical Technology Thu, 16 Oct 2025 07:00:00 GMT
 short bowel syndrome pipeline drugs insights report 2025:  openPR.com Wed, 15 Oct 2025 12:36:06 GMT
 published on: 2025-10-13 09:02:21  newser.com Mon, 13 Oct 2025 14:02:21 GMT

9 Meters Biopharma, Inc
(NASDAQ:NMTR) 

NMTR stock logo

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company i...

Founded: 2012
CEO: Sandeep Laumas  
Sector: Manufacturing
Industry: Computer Storage Device Manufacturing

Share this website to your friends